We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ADM vs. CTVA: Two Agricultural Leaders With Very Different Moats
Read MoreHide Full Article
Key Takeaways
ADM combines global processing scale with growth in nutrition, natural colors and precision fermentation.
CTVA gains from Enlist adoption, branded corn leadership in Brazil and differentiated crop protection.
ADM's 9.7% three-month return and 15.18X forward P/E compare with CTVA's 0.3% rise and 20.41X.
Archer-Daniels-Midland Company (ADM - Free Report) and Corteva, Inc. (CTVA - Free Report) sit at different but strategically important points of the global agricultural value chain. ADM derives its strength from an expansive origination, transportation, processing and ingredients network spanning oilseeds, grains, biofuels and nutrition, giving it scale and flexibility when trade flows shift.
Corteva, by contrast, competes through intellectual property, seed genetics and differentiated crop-protection technologies sold directly into the farm economy. Its Enlist platform is expected to cover about 65% of U.S. soybean acres in 2026, while Corteva's branded corn business holds the No. 1 position in Brazil. Thus, the face-off is less about two identical competitors and more about ADM's infrastructure-led scale versus Corteva's technology-led market share and pricing power.
The Investment Case for ADM
Archer-Daniels-Midland commands a strong position across the global agricultural value chain, supported by its extensive origination, processing, transportation and distribution network. The company’s broad asset footprint gives it flexibility to respond to shifts in commodity flows, trade patterns and regional demand. Recent performance in Ag Services and Oilseeds reflected effective commercial execution and higher utilization across processing assets. ADM’s competitive standing is therefore anchored less in consumer-facing market share and more in its scale across agricultural processing, biofuels, food ingredients and nutrition.
ADM is also reshaping its portfolio toward differentiated, higher-value businesses that can improve the quality of earnings over time. Natural colors have emerged as an important growth avenue as food and beverage manufacturers increasingly move toward cleaner-label formulations. The company is leveraging its established expertise in colors, flavors and formulation capabilities to support customers through this transition. Flavors are also gaining traction across international markets, while improving Specialty Ingredients performance is strengthening the broader Human Nutrition platform.
Innovation remains an important pillar of ADM’s long-term strategy. The company is expanding precision-fermentation capabilities to develop applications across human nutrition, pet food and natural ingredients, while also pursuing opportunities in plant proteins, postbiotics and fiber. These initiatives broaden ADM’s exposure to changing consumer preferences around health, wellness and ingredient transparency. At the same time, investments in automation, digitization and cybersecurity are intended to improve operating efficiency and strengthen the company’s technological foundation across its global operations.
From a financial standpoint, ADM is benefiting from stronger operating performance across its major businesses, with Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition all contributing to improved profitability. Nutrition has shown particularly encouraging margin progress despite softer revenues, supported by Flavors growth and portfolio actions. Healthy cash generation and a manageable leverage position provide ADM with flexibility to fund organic expansion while maintaining capital discipline. The company is prioritizing lower-cost brownfield capacity additions, particularly in crushing and ethanol, which could enhance returns while supporting future growth.
The Investment Case for CTVA
Corteva holds a strong competitive position across seeds and crop protection, supported by proprietary technology, established brands and growing farmer adoption. Its Enlist platform has become a leading soybean technology in the United States, while the company also maintains a prominent position in branded corn in Brazil. Corteva is looking to deepen its presence in Brazil’s soybean market as well. Its licensing model is broadening the reach of key technologies through independent seed companies, strengthening Corteva’s farm-gate presence beyond its directly marketed brands.
The portfolio is anchored by established seed brands such as Pioneer and Brevant, supported by proprietary germplasm and an expanding trait-licensing business. On the Crop Protection side, Corteva is emphasizing differentiated chemistry, biologicals and newer technologies rather than relying heavily on commoditized products. Its development pipeline includes new active ingredients, biological solutions, hybrid wheat and next-generation traits. This breadth gives Corteva exposure to multiple areas of farmer spending while helping the company position its offerings around yield improvement, crop protection and input efficiency.
Innovation is central to Corteva’s strategy, with gene editing, biotechnology and advanced genetics shaping the next phase of portfolio development. Management is also expanding opportunities beyond traditional corn and soybean markets through hybrid wheat and biofuel-oriented crop systems. Biological products are gaining importance, particularly in Latin America, where farmers are seeking solutions that can support productivity amid elevated fertilizer costs. Corteva’s target customer remains the value-conscious grower willing to adopt premium technologies when they can improve yields, protect crops or enhance farm economics.
Financial performance reflects the benefits of this technology-led positioning. Organic growth has been supported by gains across both Seed and Crop Protection, while favorable price and mix in Seed and rising volumes in newer Crop Protection products have strengthened operating performance. Productivity initiatives, lower input costs and reduced royalty expenses are also supporting margin expansion. Corteva expects its Seed business to move toward a more favorable royalty position, which could further improve earnings quality. The broader investment case rests on converting proprietary innovation, licensing expansion and differentiated products into sustained market penetration and stronger profitability.
How Do Estimates Compare for ADM & CTVA?
The Zacks Consensus Estimate for Archer-Daniels-Midland’s fiscal 2026 EPS suggests year-over-year growth of 52.2%, while the estimate for fiscal 2027 indicates an increase of 3.5%. ADM’s EPS estimates have been stable in the past 30 days.
ADM’s Estimate Revision Trend
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Corteva’s 2026 sales and EPS suggests year-over-year growth of 4.1% and 11.4%, respectively. The EPS estimate has been stable in the past 30 days.
CTVA’s Estimate Revision Trend
Image Source: Zacks Investment Research
Price Performance & Valuation of ADM & CTVA
In the past three months, ADM stock has had the edge in terms of performance, having recorded a total return of 9.7%. This has noticeably outpaced CTVA's 0.3% rise.
ADM vs. CTVA: 3-Month Price Performance
Image Source: Zacks Investment Research
From a valuation perspective, ADM trades at a forward price-to-earnings (P/E) multiple of 15.18X. Moreover, CTVA stock trades above Archer-Daniels-Midland’s forward 12-month P/E multiple of 20.41X.
Image Source: Zacks Investment Research
The valuation gap suggests that investors are currently assigning a richer premium to CTVA, potentially reflecting expectations for stronger growth from its differentiated seed and crop-protection portfolio. In contrast, ADM combines stronger recent share-price performance with a lower earnings multiple, making the valuation comparison particularly noteworthy.
ADM vs. CTVA: Which Is the Better Bet Now?
In comparing the two, both companies offer distinct investment narratives, but with different risk-reward profiles. Archer-Daniels-Midland stands out for its diversified agricultural platform, improving operating performance, stronger recent price momentum and relatively attractive valuation. Corteva, on the other hand, offers a technology-driven growth story supported by leadership in seeds, crop protection and biologicals, but its richer valuation makes the near-term setup comparatively less compelling. ADM’s combination of earnings growth prospects, valuation support and stronger market performance gives it an edge at this stage, making it the relatively better bet for investors.
ADM currently sports a Zacks Rank #1 (Strong Buy), while CTVA has a Zacks Rank #3 (Hold).
View the Zacks #1 Rank List
Image: Bigstock
ADM vs. CTVA: Two Agricultural Leaders With Very Different Moats
Key Takeaways
Archer-Daniels-Midland Company (ADM - Free Report) and Corteva, Inc. (CTVA - Free Report) sit at different but strategically important points of the global agricultural value chain. ADM derives its strength from an expansive origination, transportation, processing and ingredients network spanning oilseeds, grains, biofuels and nutrition, giving it scale and flexibility when trade flows shift.
Corteva, by contrast, competes through intellectual property, seed genetics and differentiated crop-protection technologies sold directly into the farm economy. Its Enlist platform is expected to cover about 65% of U.S. soybean acres in 2026, while Corteva's branded corn business holds the No. 1 position in Brazil. Thus, the face-off is less about two identical competitors and more about ADM's infrastructure-led scale versus Corteva's technology-led market share and pricing power.
The Investment Case for ADM
Archer-Daniels-Midland commands a strong position across the global agricultural value chain, supported by its extensive origination, processing, transportation and distribution network. The company’s broad asset footprint gives it flexibility to respond to shifts in commodity flows, trade patterns and regional demand. Recent performance in Ag Services and Oilseeds reflected effective commercial execution and higher utilization across processing assets. ADM’s competitive standing is therefore anchored less in consumer-facing market share and more in its scale across agricultural processing, biofuels, food ingredients and nutrition.
ADM is also reshaping its portfolio toward differentiated, higher-value businesses that can improve the quality of earnings over time. Natural colors have emerged as an important growth avenue as food and beverage manufacturers increasingly move toward cleaner-label formulations. The company is leveraging its established expertise in colors, flavors and formulation capabilities to support customers through this transition. Flavors are also gaining traction across international markets, while improving Specialty Ingredients performance is strengthening the broader Human Nutrition platform.
Innovation remains an important pillar of ADM’s long-term strategy. The company is expanding precision-fermentation capabilities to develop applications across human nutrition, pet food and natural ingredients, while also pursuing opportunities in plant proteins, postbiotics and fiber. These initiatives broaden ADM’s exposure to changing consumer preferences around health, wellness and ingredient transparency. At the same time, investments in automation, digitization and cybersecurity are intended to improve operating efficiency and strengthen the company’s technological foundation across its global operations.
From a financial standpoint, ADM is benefiting from stronger operating performance across its major businesses, with Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition all contributing to improved profitability. Nutrition has shown particularly encouraging margin progress despite softer revenues, supported by Flavors growth and portfolio actions. Healthy cash generation and a manageable leverage position provide ADM with flexibility to fund organic expansion while maintaining capital discipline. The company is prioritizing lower-cost brownfield capacity additions, particularly in crushing and ethanol, which could enhance returns while supporting future growth.
The Investment Case for CTVA
Corteva holds a strong competitive position across seeds and crop protection, supported by proprietary technology, established brands and growing farmer adoption. Its Enlist platform has become a leading soybean technology in the United States, while the company also maintains a prominent position in branded corn in Brazil. Corteva is looking to deepen its presence in Brazil’s soybean market as well. Its licensing model is broadening the reach of key technologies through independent seed companies, strengthening Corteva’s farm-gate presence beyond its directly marketed brands.
The portfolio is anchored by established seed brands such as Pioneer and Brevant, supported by proprietary germplasm and an expanding trait-licensing business. On the Crop Protection side, Corteva is emphasizing differentiated chemistry, biologicals and newer technologies rather than relying heavily on commoditized products. Its development pipeline includes new active ingredients, biological solutions, hybrid wheat and next-generation traits. This breadth gives Corteva exposure to multiple areas of farmer spending while helping the company position its offerings around yield improvement, crop protection and input efficiency.
Innovation is central to Corteva’s strategy, with gene editing, biotechnology and advanced genetics shaping the next phase of portfolio development. Management is also expanding opportunities beyond traditional corn and soybean markets through hybrid wheat and biofuel-oriented crop systems. Biological products are gaining importance, particularly in Latin America, where farmers are seeking solutions that can support productivity amid elevated fertilizer costs. Corteva’s target customer remains the value-conscious grower willing to adopt premium technologies when they can improve yields, protect crops or enhance farm economics.
Financial performance reflects the benefits of this technology-led positioning. Organic growth has been supported by gains across both Seed and Crop Protection, while favorable price and mix in Seed and rising volumes in newer Crop Protection products have strengthened operating performance. Productivity initiatives, lower input costs and reduced royalty expenses are also supporting margin expansion. Corteva expects its Seed business to move toward a more favorable royalty position, which could further improve earnings quality. The broader investment case rests on converting proprietary innovation, licensing expansion and differentiated products into sustained market penetration and stronger profitability.
How Do Estimates Compare for ADM & CTVA?
The Zacks Consensus Estimate for Archer-Daniels-Midland’s fiscal 2026 EPS suggests year-over-year growth of 52.2%, while the estimate for fiscal 2027 indicates an increase of 3.5%. ADM’s EPS estimates have been stable in the past 30 days.
ADM’s Estimate Revision Trend
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Corteva’s 2026 sales and EPS suggests year-over-year growth of 4.1% and 11.4%, respectively. The EPS estimate has been stable in the past 30 days.
CTVA’s Estimate Revision Trend
Image Source: Zacks Investment Research
Price Performance & Valuation of ADM & CTVA
In the past three months, ADM stock has had the edge in terms of performance, having recorded a total return of 9.7%. This has noticeably outpaced CTVA's 0.3% rise.
ADM vs. CTVA: 3-Month Price Performance
Image Source: Zacks Investment Research
From a valuation perspective, ADM trades at a forward price-to-earnings (P/E) multiple of 15.18X. Moreover, CTVA stock trades above Archer-Daniels-Midland’s forward 12-month P/E multiple of 20.41X.
Image Source: Zacks Investment Research
The valuation gap suggests that investors are currently assigning a richer premium to CTVA, potentially reflecting expectations for stronger growth from its differentiated seed and crop-protection portfolio. In contrast, ADM combines stronger recent share-price performance with a lower earnings multiple, making the valuation comparison particularly noteworthy.
ADM vs. CTVA: Which Is the Better Bet Now?
In comparing the two, both companies offer distinct investment narratives, but with different risk-reward profiles. Archer-Daniels-Midland stands out for its diversified agricultural platform, improving operating performance, stronger recent price momentum and relatively attractive valuation. Corteva, on the other hand, offers a technology-driven growth story supported by leadership in seeds, crop protection and biologicals, but its richer valuation makes the near-term setup comparatively less compelling. ADM’s combination of earnings growth prospects, valuation support and stronger market performance gives it an edge at this stage, making it the relatively better bet for investors.
ADM currently sports a Zacks Rank #1 (Strong Buy), while CTVA has a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank stocks here.